We also demonstrated that subjects with MetS had significantly increased IL-6 concentrations than those without MetS, both at initial and annual assessment (p < 0.01), while a significant reduction in IL-6 was observed following the implementation of the lifestyle intervention program. This evidence concerns the gene IL6 and metabolic syndrome.